Muscular dystrophy - Clinical trials 

  • Clinical trials

Clinical trials for Muscular dystrophy

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Muscular dystrophy. For all clinical trials, go to clinical trials search

This list shows clinical trials for Muscular dystrophy

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Muscular dystrophy
Title Recruitment status Location
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy Recruiting United Kingdom
A double-blind randomised multi-centre, placebo-controlled trial of combined angiotensin converting enzyme-inhibitor and beta-blocker therapy in preventing the development of cardiomyopathy in genetically characterised males with Duchenne Muscular Dystrophy without echo-detectable left ventricular dysfunction Recruiting United Kingdom
A randomised controlled trial of a home based, targeted progressive exercise programme aimed at improving endurance and function in adults with muscular dystrophy (MD). Not recruiting United Kingdom
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy Not recruiting United Kingdom
A Phase 2b Extension Study of PTC124 in Subjects with Nonsense– Mutation-Mediated Duchenne and Becker Muscular Dystrophy Not Recruiting United Kingdom
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy Not Recruiting United Kingdom
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects with Nonsense-Mutation-Mediated Duchenne and Becker Muscular Dystrophy Not Recruiting United Kingdom
A Phase 2b Extension Study of PTC124 in Subjects with Nonsense Mutation Mediated Duchenne and Becker Muscular Dystrophy Not Recruiting United Kingdom
Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients Not recruiting United Kingdom
Dose-ranging study of AVI-4658 to induce dystrophin expression in selected duchenne muscular dystrophy (DMD) patients Not recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member